Cargando…
Anno 2021: Which antivirals for the coming decade?
Despite considerable progress in the development of antiviral drugs, among which anti-immunodeficiency virus (HIV) and anti-hepatitis C virus (HCV) medications can be considered real success stories, many viral infections remain without an effective treatment. This not only applies to infectious out...
Autores principales: | Groaz, Elisabetta, De Clercq, Erik, Herdewijn, Piet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563371/ https://www.ncbi.nlm.nih.gov/pubmed/34744210 http://dx.doi.org/10.1016/bs.armc.2021.09.004 |
Ejemplares similares
-
Phosphorus Pentachloride Promoted gem-Dichlorination of 2′- and 3′-Deoxynucleosides
por: da Paixao Soares, Fabio, et al.
Publicado: (2018) -
Three decades of antiviral drugs
por: Clercq, Erik De
Publicado: (2007) -
O-2-Alkylated Cytosine Acyclic Nucleoside Phosphonamidate Prodrugs Display Pan-Genotype Antiviral Activity against African Swine Fever Virus
por: Goulding, Leah V., et al.
Publicado: (2022) -
Influence of 4′-Substitution on the Activity
of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2
por: Zheng, Zihua, et al.
Publicado: (2020) -
Highly stable hexitol based XNA aptamers targeting the vascular endothelial growth factor
por: Eremeeva, Elena, et al.
Publicado: (2019)